Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...
In Depth
Mayo Clinic on MSN2hIn Depth
COVID-19 vaccines: Get the facts
Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European Medicines Agency’s (EMA) CHMP for use in individuals aged six months and older.
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
We recently compiled a list of the Best Future Stocks For The Long-Term. In this article, we will look at where Pfizer Inc.
New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
XEC is also an offshoot of omicron, the widely spread variant that formed in 2021. According to experts, it has some of omicron’s features, too — like less severe symptoms and easy transmissibility.
Jackson County Health Department (JCHD) is now providing flu vaccinations by appointment. An annual flu vaccination is ...
Pfizer (PFE) closed the latest trading day at $29.42, indicating a -0.83% change from the previous session's end. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow gained 0.09%, ...
Shares of Pfizer Inc. PFE dropped 0.81% to $29.42 Friday, on what proved to be an all-around mixed trading session for the ...